Table 2 pathological data in inflammatory breast cancer tumors
Variables | Number of patients | Percentage (%) |
|---|---|---|
ER | ||
 Positive | 99 | 55.6 |
 Negative | 79 | 44.4 |
 Unknown | 41 | – |
PgR | ||
 Positive | 124 | 69.7 |
 Negative | 54 | 30.3 |
 Unknown | 41 | – |
Her2 | ||
 Positive | 41 | 35.3 |
 Negative | 75 | 64.7 |
 Unknown | 103 | – |
Molecular subtype | ||
 Luminal A | 43 | 38.7 |
 Luminal B Her2 – | 5 | 4.5 |
 Luminal B Her2 + | 31 | 27.9 |
 Her2 | 8 | 7.2 |
 Triple negative | 24 | 21.6 |
 Unknown | 108 | – |
Tumor size | ||
 ≤ 20 mm | 27 | 15.7 |
 21–50 mm | 55 | 32.0 |
 > 50 mm | 90 | 52.3 |
 Unknown | 47 | – |
Lymph nodes | ||
 N0 | 66 | 30.1 |
 N1 | 84 | 38.4 |
 N2 | 45 | 20.5 |
 N3 | 24 | 11.0 |
Histological type | ||
 Invasive carcinoma of NST | 212 | 96.8 |
 Invasive lobular carcinoma | 4 | 1.8 |
 Others | 3 | 1.4 |
Vascular invasion | ||
 Yes | 119 | 54.3 |
 No | 100 | 45.7 |
SBR grade | ||
 SBR I | 15 | 7.1 |
 SBR II | 110 | 52.1 |
 SBR III | 86 | 40.8 |
 Unknown | 8 | – |